Blood · 2021 · 86 citations · 29 references
MedicineOncologyPediatricsChemotherapyPediatric HematologyPediatric OncologyPediatric Central Nervous System RadiotherapyPediatric LeukemiasPediatric Radiation OncologyAcute Lymphoblastic Leukemia BiologyAcute Lymphoblastic Leukemia TherapyAcute Lymphoblastic Leukemia TreatmentIrradiation EffectsPediatric Cranial IrradiationPrognostic Factors AnalysisProphylactic Cranial Irradiation
To identify the prognostic factors that are useful to improve central nervous system (CNS) control in children with acute lymphoblastic leukemia (ALL), we analyzed the outcome of 7640 consecutive patients treated on Chinese Children's Cancer Group ALL-2015 protocol between 2015 and 2019. This protocol featured prephase dexamethasone treatment before conventional remission induction and subsequent risk-directed therapy, including 16 to 22 triple intrathecal treatments, without prophylactic cranial irradiation. The 5-year event-free survival was 80.3% (95% confidence interval [CI], 78.9-81.7), and overall survival 91.1% (95% CI, 90.1-92.1). The cumulative risk of isolated CNS relapse was 1.9% (95% CI, 1.5-2.3), and any CNS relapse 2.7% (95% CI, 2.2-3.2). The isolated CNS relapse rate was significantly lower in patients with B-cell ALL (B-ALL) than in those with T-cell ALL (T-ALL) (1.6%; 95% CI, 1.2-2.0 vs 4.6%; 95% CI, 2.9-6.3; P < .001). Independent risk factors for isolated CNS relapse included male sex (hazard ratio [HR], 1.8; 95% CI, 1.1-3.0; P = .03), the presence of BCR-ABL1 fusion (HR, 3.8; 95% CI, 2.0-7.3; P < .001) in B-ALL, and presenting leukocyte count ≥50×109/L (HR, 4.3; 95% CI, 1.5-12.2; P = .007) in T-ALL. Significantly lower isolated CNS relapse was associated with the use of total intravenous anesthesia during intrathecal therapy (HR, 0.2; 95% CI, 0.04-0.7; P = .02) and flow cytometry examination of diagnostic cerebrospinal fluid (CSF) (HR, 0.2; 95% CI, 0.06-0.6; P = .006) among patients with B-ALL. Prephase dexamethasone treatment, delayed intrathecal therapy, use of total intravenous anesthesia during intrathecal therapy, and flow cytometry examination of diagnostic CSF may improve CNS control in childhood ALL. This trial was registered with the Chinese Clinical Trial Registry (ChiCTR-IPR-14005706).
29
The Statistical Analysis of Failure Time Data
John P. Klein · Technometrics · 1982 · 2.2K citations
Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
Ching-Hon Pui, Dario Campana, Deqing Pei et al. · New England Journal of Medicine · 2009 · 1.2K citations · Full text
Medicine, Oncology, Pediatrics +12
Stephen P. Hunger, Xiaomin Lu, Meenakshi Devidas et al. · Journal of Clinical Oncology · 2012 · 1.2K citations · Full text
Medicine, Oncology, Pediatrics +7
Ajay Vora, Nick Goulden, Rachel Wade et al. · The Lancet Oncology · 2013 · 483 citations · Full text
Medicine, Hematology, Oncology +16